Navigation Links
Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
Date:1/31/2008

rrent business model and working with our management team to find approaches to help us operate more efficiently over the long-term, and continue as a driving force in global healthcare."

2007 Fourth Quarter and Full Year Product Highlights

Set forth below is a table of net revenue for Wyeth's principal products for the 2007 fourth quarter and full year together with the percentage changes from the comparable period in the prior year:

(UNAUDITED)

Three Months Ended Full Year Ended

12/31/2007 12/31/2007

Increase/ Increase/

($ in millions) (Decrease) ($ in millions) (Decrease)

Principal Products

Effexor $968 3% $3,794 2%

Prevnar 556 11% 2,439 24%

Enbrel (outside the

U.S. and Canada) 565 36% 2,045 36%

Protonix 461 10% 1,911 6%

Nutrition 393 28% 1,443 20%

Alliance Revenue (1) 321 (13)% 1,294 (3)%

Zosyn/Tazocin 292 17% 1,137 17%

Premarin Family 264 1% 1,055 0%

Centrum 204 13% 705 7%

Advil 186 8% 684 10%

(1) Alliance revenue reflects revenue to Wyeth derived from sales of

Enbrel (in the United States and Canada), Altace and the CYPHER stent.

Product Highlights

Enbrel(R) continued to post strong revenue growth during 2007. Enbrel sales in the United States and Canada, reported by Wyeth's marketing part
'/>"/>

SOURCE Wyeth
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Wyeth Sets Webcast and Conference Call for 2007 Third Quarter Earnings
2. Wyeth Announces $5 Billion Share Repurchase Program; Declares Increase in Common Stock Dividend
3. Wyeth Pharmaceuticals Acquires Haptogen Ltd. to Boost Biotechnology Drug Discovery
4. Wyeth Announces Election of New Principal Corporate Officer
5. Wyeth Declares Preferred Stock Dividend
6. Raven biotechnologies, inc. and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies
7. Wyeth Provides Update on Regulatory Review of Viviant (bazedoxifene)
8. Pfizer, Genentech, Amgen, Bayer, Wyeth, Abbott, Merck and Additional Leading Pharmaceutical Companies Participating During ExL Pharmas Fall Line Up!
9. Wyeth Will Pursue Claim for Damages Resulting From Teva Pharmaceuticals Launch of Generic Pantoprazole in Violation of PROTONIX Patent
10. Wyeth Consumer Healthcare Supports U.S. Food and Drug Administration Decision for Over-the-Counter Cough and Cold Medications in Children under Two Years of Age
11. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ICO) ... Oral Amphotericin B program.  The company recently announced ... work involving samples from HIV/AIDS patients exposed to ... clinical studies and regulatory filings to move forward ... approximately $700,000 of funding and technological advice from ...
(Date:10/22/2014)... , Oct. 22, 2014 Research and ... Electronics Market by Material, by Application, Geography - Global ... their offering. Organic electronics, also called ... of material science which deals with small conductive molecules ... because small molecules and polymers are carbon based, made ...
(Date:10/20/2014)... The report “Pharmacy Automation Systems Market ... Labeling Systems, Table-top Counters) by End-user (Inpatient Pharmacy ... Trends to 2019” analyzes and studies the major ... Europe, Asia-Pacific, and the Rest of the World ... figures spread through 300 pages and in-depth TOC ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Convey ... that a team from Iowa State University won first ... contest. Using a Convey HC-2ex, the team’s solution achieved ... times faster than the second place finisher. , Experts ... embarked upon the month long challenge, using a variety ...
Breaking Biology Technology:iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 2iCo Therapeutics Announces Advancement of Oral Amphotericin B Program 3Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 2Global Organic Electronics (Semiconductor, Conductive, Dielectric and Substrate) Market - Analysis and Forecast (2014 - 2020) 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 2Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 3Pharmacy Automation Systems Market worth $4,566.2 Million by 2019 - New Research Report by MarketsandMarkets 4Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 2Team from Iowa State Wins 2014 MemoCODE Design Contest Using Convey HC-2ex 3
... Calif., Oct. 5 MAP,Pharmaceuticals, Inc. announced today that ... of common stock at a price of $12.00 per,share. ... addition,MAP Pharmaceuticals has granted the underwriters a 30-day option ... over-allotments, if,any. Merrill Lynch & Co. and Morgan Stanley ...
... the, Latest Pre-FDA Multi-Hospital Study using the AppyScore Human Appendicitis ... Blood-based ... AspenBio Pharma,Inc. (Nasdaq: APPY ) an emerging bio-pharmaceutical ... animals and humans, has been,invited to present at the Oppenheimer ...
... Oct. 5 Cerimon,Pharmaceuticals, Inc., today announced Paul ... at the 2007 BIO Investor Forum on,Thursday, October ... Palace Hotel in San,Francisco. The presentation will take ... Cerimon Pharmaceuticals Cerimon Pharmaceuticals, Inc. is a ...
Cached Biology Technology:MAP Pharmaceuticals Announces Pricing of Its Initial Public Offering 2AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference 2AspenBio Pharma to Present at the Oppenheimer Best Ideas 1x1 Conference 3
(Date:10/15/2014)... , Oct. 15, 2014   Neurotechnology , ... announced the availability of the VeriLook Surveillance ... 3.0 provides real-time biometric face identification using live ... surveillance cameras. The new version not only identifies ... people from objects while they are moving through ...
(Date:10/14/2014)... of years since T. rex took its ... scientists is breathing life back into dinosaurs using high-powered ... research has important implications for how dinosaurs used their ... sense of smell and cool their brains. , ... student Jason Bourke, lead author of the new study ...
(Date:10/14/2014)... kind of stem cell that can become either a liver ... to a study published today in the journal Stem ... contradicts current theory on how organs arise from cell layers ... and future treatment for, liver cancer., Thanks to stem cells, ... made up of more than 200 cell types. The original, ...
Breaking Biology News(10 mins):VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 2VeriLook Surveillance 3.0 SDK Identifies Faces and Moving Objects, Differentiates Pedestrians from Other Moving Objects in Video Surveillance Systems 3Dinosaur breathing study shows that noses enhanced smelling and cooled brain 2Dinosaur breathing study shows that noses enhanced smelling and cooled brain 3Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 2Stem cell discovery challenges dogma on how fetus develops; holds insights for liver cancer and reg 3
... Faculty of Medicine & Dentistry at the University of ... neurons. This finding is significant because a specific type ... community as a potential treatment for MS and other ... fellow, Yohannes Haile, both from the Division of Neurology, ...
... they comprise most of the Earth,s total biodiversity and play key ... life in and on it, going. One of the global processes ... is currently unbalanced. Humans release more carbon into the atmosphere than ... Mighty Microbes Respond," is a free panel discussion set to take ...
... DALLAS May 6, 2011 Cancer researchers at ... of the telomerase enzyme, which is linked to the disease,s ... Cell , demonstrate that telomerase repairs chromosomes in one of ... normally or if the cell is under stress from enzyme ...
Cached Biology News:Discovery demonstrates potential MS therapy could kill brain cells 2UT Southwestern research reveals how cancer-driving enzyme works 2
...
...
Immunogen: Peptide corresponding to amino acid residues from the N-terminal region of human thyroid hormone receptor, alpha1/alpha2-isotype. Storage: -20 C, Avoid Freeze/Thaw Cycles...
Antibodies were affinity purified using epitopes specific to QKI immobilized on solid support....
Biology Products: